Rodney J Ellis

Summary

Affiliation: Case Western Reserve University
Country: USA

Publications

  1. ncbi Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancer
    Rodney J Ellis
    Department of Radiation Oncology, University Hospitals, Case Medical Center and Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    Int J Radiat Oncol Biol Phys 81:29-34. 2011
  2. ncbi Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure
    R J Ellis
    Department of Radiation Oncology, Aultman Hospital, Canton, Ohio, USA
    J Urol 179:1768-73; discussion 1773-4. 2008
  3. ncbi Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetide
    Rodney J Ellis
    Department of Radiation Oncology, Aultman Hospital, Canton, OH, USA
    Brachytherapy 6:16-25. 2007
  4. ncbi Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusion
    Rodney J Ellis
    Department of Radiation Oncology, Aultman Hospital, Canton, OH, USA
    Brachytherapy 6:149-56. 2007
  5. ncbi Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma
    Rodney J Ellis
    Department of Radiation Oncology, Aultman Hospital, Canton, OH 44708, USA
    Int J Radiat Oncol Biol Phys 57:362-70. 2003
  6. ncbi Combination conformal radiotherapy and radioimmunoguided transperineal 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinoma
    Rodney J Ellis
    Department of Radiation Oncology, Aultman Hospital, Canton, OH, USA
    Brachytherapy 2:215-22. 2003
  7. ncbi Radiotherapy and survival in prostate cancer patients: a population-based study
    Esther H Zhou
    Department of Urology, Case Western Reserve University School of Medicine, Cleveland, OH, USA
    Int J Radiat Oncol Biol Phys 73:15-23. 2009
  8. ncbi Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator
    Charles A Kunos
    Department of Radiation Oncology, University Hospitals of Cleveland, Cleveland, OH, USA
    Brachytherapy 3:71-7. 2004
  9. ncbi Role of ProstaScint for brachytherapy in localized prostate adenocarcinoma
    Rodney J Ellis
    Aultman Hospital, Department of Radiation Oncology, Canton, OH 44710, USA
    Expert Rev Mol Diagn 4:435-41. 2004
  10. ncbi Feasibility and acute toxicities of radioimmunoguided prostate brachytherapy
    R J Ellis
    Department of Radiation Oncology, University Hospitals of Cleveland, Cleveland, OH 44106, USA
    Int J Radiat Oncol Biol Phys 48:683-7. 2000

Detail Information

Publications18

  1. ncbi Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancer
    Rodney J Ellis
    Department of Radiation Oncology, University Hospitals, Case Medical Center and Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    Int J Radiat Oncol Biol Phys 81:29-34. 2011
    ....
  2. ncbi Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure
    R J Ellis
    Department of Radiation Oncology, Aultman Hospital, Canton, Ohio, USA
    J Urol 179:1768-73; discussion 1773-4. 2008
    ....
  3. ncbi Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetide
    Rodney J Ellis
    Department of Radiation Oncology, Aultman Hospital, Canton, OH, USA
    Brachytherapy 6:16-25. 2007
    ....
  4. ncbi Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusion
    Rodney J Ellis
    Department of Radiation Oncology, Aultman Hospital, Canton, OH, USA
    Brachytherapy 6:149-56. 2007
    ..To evaluate rectal morbidity after dose escalation to biologic target volumes identified by capromab pendetide (ProstaScint) single-photon emission tomography images coregistered with computed tomography (SPECT/CT)...
  5. ncbi Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma
    Rodney J Ellis
    Department of Radiation Oncology, Aultman Hospital, Canton, OH 44708, USA
    Int J Radiat Oncol Biol Phys 57:362-70. 2003
    ..To evaluate 4-year biochemical outcomes for patients with prostate adenocarcinoma who underwent radioimmunoguided (Prostascint) permanent prostate brachytherapy...
  6. ncbi Combination conformal radiotherapy and radioimmunoguided transperineal 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinoma
    Rodney J Ellis
    Department of Radiation Oncology, Aultman Hospital, Canton, OH, USA
    Brachytherapy 2:215-22. 2003
    ..To report outcomes for prostate cancer patients treated with external beam radiation therapy (EBRT) and permanent prostate brachytherapy utilizing radioimmunoguided targeting of biological tumor volumes (BTVs)...
  7. ncbi Radiotherapy and survival in prostate cancer patients: a population-based study
    Esther H Zhou
    Department of Urology, Case Western Reserve University School of Medicine, Cleveland, OH, USA
    Int J Radiat Oncol Biol Phys 73:15-23. 2009
    ....
  8. ncbi Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator
    Charles A Kunos
    Department of Radiation Oncology, University Hospitals of Cleveland, Cleveland, OH, USA
    Brachytherapy 3:71-7. 2004
    ....
  9. ncbi Role of ProstaScint for brachytherapy in localized prostate adenocarcinoma
    Rodney J Ellis
    Aultman Hospital, Department of Radiation Oncology, Canton, OH 44710, USA
    Expert Rev Mol Diagn 4:435-41. 2004
    ....
  10. ncbi Feasibility and acute toxicities of radioimmunoguided prostate brachytherapy
    R J Ellis
    Department of Radiation Oncology, University Hospitals of Cleveland, Cleveland, OH 44106, USA
    Int J Radiat Oncol Biol Phys 48:683-7. 2000
    ..Additionally, the acute toxicity results from the first 43 patients treated with this technique are reviewed...
  11. ncbi Radioimmunoguided imaging of prostate cancer foci with histopathological correlation
    R J Ellis
    Department of Radiation Oncology, University Hospitals of Cleveland, Cleveland, OH 44106, USA
    Int J Radiat Oncol Biol Phys 49:1281-6. 2001
    ..We now correlate areas of increased intensity seen on ProstaScint-CT fusion images to biopsy results in a series of 7 patients to evaluate the accuracy of this technique in localizing intraprostatic disease...
  12. ncbi Radioactive seed migration after transperineal interstitial prostate brachytherapy and associated development of small-cell lung cancer
    William C Chen
    Department of Radiation Oncology, Case Comprehensive Cancer Center, University Hospitals of Cleveland, Cleveland, OH 44106, USA
    Brachytherapy 11:354-8. 2012
    ..We report a case of lung carcinoma developing in the location of a migrated prostate brachytherapy seed...
  13. ncbi Stereotactic body radiation therapy for metastasis to the adrenal glands
    Kevin Shiue
    Case Western Reserve University School of Medicine, Cleveland, OH, USA
    Expert Rev Anticancer Ther 12:1613-20. 2012
    ..This review focuses on the emerging data on SBRT of metastasis to the adrenal glands, while also providing a brief discussion of the overall management of adrenal metastasis...
  14. ncbi Intraoperative radiotherapy in the multimodality approach to bone and soft tissue cancers
    Rodney J Ellis
    Department of Radiation Oncology, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Cleveland, OH 44106-6068, USA
    Surg Oncol Clin N Am 12:1015-29. 2003
    ..As IORT use becomes more common, special care will be required to ensure that it is used by a multidisciplinary team of radiation oncologists and surgeons to ensure the best results for patients...
  15. ncbi Brachytherapy: update and results
    Rodney J Ellis
    Aultman Hospital, Department of Radiation Oncology, PO Box 80468, Canton, OH 44708, USA. edu
    Curr Urol Rep 4:233-9. 2003
    ..This article describes current techniques, treatment issues, and clinical results of permanent seed implants...
  16. ncbi Stereotactic body radiation therapy for prostate cancer
    Hiromichi Ishiyama
    Department of Radiation Oncology, The Methodist Hospital and Research Institute, Houston, TX 77030, USA
    Future Oncol 7:1077-86. 2011
    ..The purpose of this article is to examine radiobiological, technical and clinical aspects of SBRT for prostate cancer...
  17. ncbi Alternative techniques of intraoperative radiotherapy
    R J Ellis
    University Hospitals of Cleveland, Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
    Eur J Surg Oncol 26:S25-7. 2000
    ..The article reviews current techniques for the delivery of intraoperative radiotherapy (IORT)...
  18. ncbi American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy
    Subir Nag
    American Brachytherapy Society, Oakbrook, IL, USA
    Int J Radiat Oncol Biol Phys 54:462-70. 2002
    ..To standardize the reporting of brachytherapy-related prostate morbidity to guide ongoing clinical practice and future investigations...